文献速递儿科影像腹部泌尿生殖US

超声造影与超声引导活检在儿童腹部及盆腔肿瘤中的对比:一项倾向性评分匹配研究

Contrast-enhanced US versus US-guided biopsy for abdominal and pelvic neoplasm in paediatric patients: a propensity score matching study.
PubMed 文献 · Eur Radiol · 2024-08-14

回顾性纳入2005年4月至2022年5月764例腹部及盆腔肿瘤患儿,比较超声造影引导活检(CEUS-GB)与常规超声引导活检(US-GB)的诊断效能与并发症。CEUS-GB组样本充足率100%高于US-GB组97.4%(p<0.001);总体诊断准确率两组98.7%对97.3%无显著差异(p=0.551),倾向性评分匹配后CEUS-GB组98.7%高于US-GB组92.7%(p=0.020)。US-GB组2例(0.3%)出现活检相关并发症(CTCAE 1-2级),CEUS-GB组无不良反应。

要点

  • CEUS-GB组样本充足率100%(151/151)高于US-GB组97.4%(597/613),p<0.001。
  • 倾向性评分匹配后CEUS-GB组诊断准确率98.7%(149/151)高于US-GB组92.7%(140/151),p=0.020。
  • CEUS-GB组无不良反应,US-GB组2例(0.3%)出现CTCAE 1-2级活检相关并发症。

核心结论

  • CEUS-GB是儿童腹部及盆腔肿瘤有效且安全的活检方法,诊断准确率高于US-GB,尤其适用于含坏死区域的肿瘤。

研究设计与样本

  • 回顾性研究,纳入2005年4月至2022年5月764例年龄<18岁的腹部及盆腔肿瘤患儿(CEUS-GB组151例,US-GB组613例),采用倾向性评分匹配比较两组诊断效能并分析并发症。

诊断标准与关键数值

  • 以病理诊断为恶性肿瘤为真阳性,良性病变由病理或至少6个月临床随访确认;CEUS-GB组样本充足率100%(151/151)vs US-GB组97.4%(597/613),p<0.001;总体诊断准确率CEUS-GB组98.7%(149/151)vs US-GB组97.3%(581/597),p=0.551;倾向性评分匹配队列CEUS-GB组98.7%(149/151)vs US-GB组92.7%(140/151),p=0.020。

临床应用与阅片要点

  • 当彩色多普勒超声无法确定活检部位时,可考虑在该人群中使用CEUS引导(原文Key Points)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the diagnostic performance of CEUS-guided biopsy (CEUS-GB) and ultrasound-guided biopsy (US-GB) in evaluating abdominal and pelvic (abdominopelvic) neoplasms in paediatric patients.

METHODS: Patients aged < 18 years with abdominopelvic tumours who underwent either CEUS-GB or US-GB between April 2005 and May 2022 were retrospectively evaluated. Tumours diagnosed as malignancies by pathology were considered true-positive findings. Benign lesions were identified by pathology or clinical follow-up of at least 6 months. The diagnostic performance of the two groups was compared using propensity score matching (PSM). Complications were also analysed.

RESULTS: The present study included 764 paediatric patients (437 boys; median age, 24 months; interquartile range, 10-60 months); 151 were in the CEUS-GB group, and 613 were in the US-GB group. The sample adequacy rate was 100% (151 of 151) for the CEUS-GB group, which was greater than the 97.4% (597 of 613) for the US-GB group (p < 0.001). The overall diagnostic accuracy of the CEUS-GB group and US-GB group was 98.7% (149 of 151) versus 97.3% (581 of 597) in the total cohort (p = 0.551) and 98.7% (149 of 151) versus 92.7% (140 of 151) in the PSM cohort (p = 0.020). Two patients (0.3%) in the US-GB group experienced complications (Common Terminology Criteria for Adverse Events (CTCAE), grade 1-2) correlated with the biopsy. No adverse reactions occurred in the CEUS-GB group.

CONCLUSION: CEUS-GB of abdominopelvic tumours in paediatric patients is an effective and safe procedure with greater diagnostic accuracy than US-GB, especially for tumours with necrotic areas.

CLINICAL RELEVANCE STATEMENT: Contrast-enhanced US-guided biopsy of solid abdominal and pelvic tumours in paediatric patients is an effective and safe procedure with greater diagnostic accuracy than US-guided biopsy, especially for tumours with necrotic areas.

KEY POINTS: Contrast-enhanced ultrasound (CEUS) may be superior to conventional ultrasound at guiding biopsy of abdominopelvic masses in paediatric patients. CEUS-guided core needle biopsy of abdominopelvic masses in children was safe and resulted in a diagnostic yield of 98.7%. CEUS guidance should be considered in this population when colour Doppler US is unable to determine a biopsy site.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu M, Liu Y, Zhou W, et al. Contrast-enhanced US versus US-guided biopsy for abdominal and pelvic neoplasm in paediatric patients: a propensity score matching study. Eur Radiol. 2024. PMID: 39143246. doi:10.1007/s00330-024-11018-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。